Sinopharm Group Dividends and Buybacks
Dividend criteria checks 4/6
Sinopharm Group is a dividend paying company with a current yield of 3.65% that is well covered by earnings.
Key information
3.7%
Dividend yield
0.2%
Buyback Yield
| Total Shareholder Yield | 3.8% |
| Future Dividend Yield | 4.4% |
| Dividend Growth | 7.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 30% |
Recent dividend and buyback updates
Recent updates
Sinopharm Group Co. Ltd. (HKG:1099) Shares Could Be 23% Below Their Intrinsic Value Estimate
Oct 28
Be Wary Of Sinopharm Group (HKG:1099) And Its Returns On Capital
Oct 02Improved Earnings Required Before Sinopharm Group Co. Ltd. (HKG:1099) Shares Find Their Feet
Sep 14Is Sinopharm Group (HKG:1099) A Risky Investment?
Jul 28There Are Reasons To Feel Uneasy About Sinopharm Group's (HKG:1099) Returns On Capital
Jul 03There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding
May 27We Think You Can Look Beyond Sinopharm Group's (HKG:1099) Lackluster Earnings
May 06Earnings Miss: Sinopharm Group Co. Ltd. Missed EPS By 12% And Analysts Are Revising Their Forecasts
Mar 26Sinopharm Group (HKG:1099) Is Reinvesting At Lower Rates Of Return
Mar 19Sinopharm Group Co. Ltd.'s (HKG:1099) Share Price Is Matching Sentiment Around Its Earnings
Feb 25Sinopharm Group (HKG:1099) Has A Pretty Healthy Balance Sheet
Dec 30At HK$20.45, Is It Time To Put Sinopharm Group Co. Ltd. (HKG:1099) On Your Watch List?
Nov 26Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 1099's dividend payments have been volatile in the past 10 years.
Growing Dividend: 1099's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Sinopharm Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (1099) | 3.7% |
| Market Bottom 25% (HK) | 2.5% |
| Market Top 25% (HK) | 6.7% |
| Industry Average (Healthcare) | 3.7% |
| Analyst forecast (1099) (up to 3 years) | 4.4% |
Notable Dividend: 1099's dividend (3.65%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.55%).
High Dividend: 1099's dividend (3.65%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.75%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (30%), 1099's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (11.4%), 1099's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 09:26 |
| End of Day Share Price | 2025/11/19 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sinopharm Group Co. Ltd. is covered by 35 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Mann | Barclays |
| Bo Li | BofA Global Research |
| Xiwan Jin | CCB International Securities Limited |